80 FR 57833 - Center For Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 186 (September 25, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 186 (September 25, 2015)
| Page Range | 57833-57834 | |
| FR Document | 2015-24320 |
[Federal Register Volume 80, Number 186 (Friday, September 25, 2015)] [Notices] [Pages 57833-57834] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-24320] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cell Biology. Date: October 14, 2015. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: John Burch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, 301-408- 9519, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Oncology 2--Translational Clinical Integrated Review Group; Clinical Oncology Study Section. Date: October 19, 2015. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Reston Hotel, 11810 Sunrise Valley Drive, Reston, VA 20191. Contact Person: Malaya Chatterjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-806-2515, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cancer, Cardiovascular and Sleep Epidemiology Panel B Study Section. Date: October 19-20, 2015. Time: 8:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Avenue NW., Washington, DC 20037. Contact Person: Ellen K. Schwartz, EDD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3144, MSC 7770, Bethesda, MD 20892, 301-828-6146, [email protected]. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Virology--A Study Section. Date: October 26-27, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Washington DC, Dupont Circle, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD 20892, 301-496-6980, [email protected]. Name of Committee: Immunology Integrated Review Group; Innate Immunity and Inflammation Study Section. Date: October 29-30, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Alexandria-Old Town, 1900 Diagonal Road, Alexandria, VA 22314. Contact Person: Tina McIntyre, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD 20892, 301-594- 6375, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Special Topic: Development Functions and Immune Mediated Diseases. Date: October 30, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Capital View, 2850 South Potomac Avenue, Arlington, VA 22202. Contact Person: Deborah Hodge, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4207 MSC 7812, Bethesda, MD 20892, (301) 435- 1238, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PARs: Developing and Testing Interventions for Health- Enhancing Physical Activity. Date: October 30, 2015. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. [[Page 57834]] Place: The Fairmont Washington, DC, 2401 M Street NW., Washington, DC 20037. Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD 20892, (301) 594-3292, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Infection, Complement Activation and Inflammatory Immune Tolerance. Date: October 30, 2015. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Bahiru Gametchu, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4204, MSC 7812, Bethesda, MD 20892, 301-435-1225, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 21, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-24320 Filed 9-24-15; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 80, No. 186 / Friday, September 25, 2015 / Notices 57833
Upon the expiration or termination of Evaluation Option License Agreement. Health, 6701 Rockledge Drive, Room 6192,
the Start-up Exclusive Evaluation Comments and objections submitted to MSC 7804, Bethesda, MD 20892, 301–806–
Option License Agreement, Angio360 this notice will not be made available 2515, chatterm@csr.nih.gov.
Diagnostics, LLC will have the exclusive for public inspection and, to the extent Name of Committee: Center for Scientific
right to execute a Start-Up Exclusive permitted by law, will not be released Review Special Emphasis Panel; Cancer,
Cardiovascular and Sleep Epidemiology
Patent License Agreement which will under the Freedom of Information Act, Panel B Study Section.
supersede and replace the Start-up 5 U.S.C. 552. Date: October 19–20, 2015.
Exclusive Evaluation Option License Dated: September 21, 2015. Time: 8:30 a.m. to 3:00 p.m.
Agreement, with no greater field of use Richard U. Rodriguez, Agenda: To review and evaluate grant
and territory than granted in the Start- applications.
Acting Director, Office of Technology Place: Melrose Hotel, 2430 Pennsylvania
up Exclusive Evaluation Option License Transfer, National Institutes of Health.
Agreement. Avenue NW., Washington, DC 20037.
[FR Doc. 2015–24331 Filed 9–24–15; 8:45 am] Contact Person: Ellen K. Schwartz, EDD,
DATES: Only written comments and/or
BILLING CODE 4140–01–P Scientific Review Officer, Center for
applications for a license which are Scientific Review, National Institutes of
received by the NIH Office of Health, 6701 Rockledge Drive, Room 3144,
Technology Transfer on or before DEPARTMENT OF HEALTH AND MSC 7770, Bethesda, MD 20892, 301–828–
October 13, 2015 will be considered. HUMAN SERVICES 6146, schwarel@mail.nih.gov.
ADDRESSES: Requests for copies of the Name of Committee: Infectious Diseases
patent application(s), inquiries, National Institutes of Health and Microbiology Integrated Review Group;
comments, and other materials relating Virology—A Study Section.
Center For Scientific Review; Notice of Date: October 26–27, 2015.
to the contemplated Start-Up Exclusive
Closed Meetings Time: 8:00 a.m. to 5:00 p.m.
Evaluation Option License Agreement Agenda: To review and evaluate grant
should be directed to: Rose M. Freel, Pursuant to section 10(d) of the applications.
Licensing and Patenting Manager, Office Federal Advisory Committee Act, as Place: Renaissance Washington DC,
of Technology Transfer, National amended (5 U.S.C. App.), notice is Dupont Circle, 1143 New Hampshire Avenue
Institutes of Health, 6011 Executive NW., Washington, DC 20037.
hereby given of the following meetings. Contact Person: Kenneth M. Izumi, Ph.D.,
Boulevard, Suite 325, Rockville, MD The meetings will be closed to the
20852–3804; Telephone: (301) 402– Scientific Review Officer, Center for
public in accordance with the Scientific Review, National Institutes of
9521; Facsimile: (301) 402–0220; Email: provisions set forth in sections Health, 6701 Rockledge Drive, Room 3204,
rose.freel@nih.gov. A signed 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MSC 7808, Bethesda, MD 20892, 301–496–
confidentiality nondisclosure agreement as amended. The grant applications and 6980, izumikm@csr.nih.gov.
will be required to receive copies of any the discussions could disclose Name of Committee: Immunology
patent applications that have not been confidential trade secrets or commercial Integrated Review Group; Innate Immunity
published or issued by the United States property such as patentable material, and Inflammation Study Section.
Patent and Trademark Office or the and personal information concerning Date: October 29–30, 2015.
World Intellectual Property Time: 8:00 a.m. to 5:00 p.m.
individuals associated with the grant Agenda: To review and evaluate grant
Organization. applications, the disclosure of which applications.
SUPPLEMENTARY INFORMATION: This would constitute a clearly unwarranted Place: Embassy Suites Alexandria-Old
technology describes a method of invasion of personal privacy. Town, 1900 Diagonal Road, Alexandria, VA
detecting pathological angiogenesis Name of Committee: Center for Scientific 22314.
(formation of new blood vessels) using Review Special Emphasis Panel; Member Contact Person: Tina McIntyre, Ph.D.,
the expression levels of certain proteins Conflict: Cell Biology. Scientific Review Officer, Center for
Date: October 14, 2015. Scientific Review, National Institutes of
for the diagnosis of cancer or monitoring Health, 6701 Rockledge Drive, Room 4202,
response to cancer treatment. Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant MSC 7812, Bethesda, MD 20892, 301–594–
The prospective Start-Up Exclusive 6375, mcintyrt@csr.nih.gov.
Evaluation Option License Agreement is applications.
Place: National Institutes of Health, 6701 Name of Committee: Center for Scientific
being considered under the small Rockledge Drive, Bethesda, MD 20892, Review Special Emphasis Panel; Special
business initiative launched on October (Telephone Conference Call). Topic: Development Functions and Immune
1, 2011 and will comply with the terms Contact Person: John Burch, Ph.D., Mediated Diseases.
and conditions of 35 U.S.C. 209 and 37 Scientific Review Officer, Center for Date: October 30, 2015.
CFR part 404. The prospective Start-Up Scientific Review, National Institute of Time: 8:00 a.m. to 5:00 p.m.
Exclusive Evaluation Option License Health, 6701 Rockledge Drive, Room 3213, Agenda: To review and evaluate grant
MSC 7808, Bethesda, MD 20892, 301–408– applications.
Agreement and a subsequent Start-Up
9519, burchjb@csr.nih.gov. Place: Residence Inn Capital View, 2850
Exclusive Patent License Agreement This notice is being published less than 15 South Potomac Avenue, Arlington, VA
may be granted unless the NIH receives days prior to the meeting due to the timing 22202.
written evidence and argument, within limitations imposed by the review and Contact Person: Deborah Hodge, Ph.D.,
fifteen (15) days from the date of this funding cycle. Scientific Review Officer, Center for
published notice, that establishes that Name of Committee: Oncology 2— Scientific Review, National Institutes of
the grant of the contemplated Start-Up Translational Clinical Integrated Review Health, 6701 Rockledge Drive, Room 4207
Exclusive Evaluation Option License Group; Clinical Oncology Study Section. MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
mstockstill on DSK4VPTVN1PROD with NOTICES
Agreement would not be consistent with Date: October 19, 2015.
the requirements of 35 U.S.C. 209 and Time: 8:00 a.m. to 6:00 p.m. Name of Committee: Center for Scientific
Agenda: To review and evaluate grant Review Special Emphasis Panel; PARs:
37 CFR part 404.
applications. Developing and Testing Interventions for
Complete applications for a license in Place: Sheraton Reston Hotel, 11810 Health-Enhancing Physical Activity.
the prospective field of use that are filed Sunrise Valley Drive, Reston, VA 20191. Date: October 30, 2015.
in response to this notice will be treated Contact Person: Malaya Chatterjee, Ph.D., Time: 8:30 a.m. to 5:00 p.m.
as objections to the grant of the Scientific Review Officer, Center for Agenda: To review and evaluate grant
contemplated Start-Up Exclusive Scientific Review, National Institutes of applications.
VerDate Sep<11>2014 19:58 Sep 24, 2015 Jkt 235001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\25SEN1.SGM 25SEN1](https://thefederalregister.org/doc/80_FR_58019/page/1.svg)
![57834 Federal Register / Vol. 80, No. 186 / Friday, September 25, 2015 / Notices
Place: The Fairmont Washington, DC, 2401 2E904, Rockville, MD 20850, (Telephone DATES: This recertification is effective
M Street NW., Washington, DC 20037. Conference Call). for the period from September 1, 2015
Contact Person: Weijia Ni, Ph.D., Chief/ Contact Person: Gerald G. Lovinger, Ph.D., through August 31, 2016.
Scientific Review Officer, Center for Scientific Review Officer, Research
Scientific Review, National Institutes of Technology and Contract Review Branch, FOR FURTHER INFORMATION CONTACT:
Health, 6701 Rockledge Drive, Room 3100, Division of Extramural Activities, National LTJG Katharine Martorelli, Seventeenth
MSC 7808, Bethesda, MD 20892, (301) 594– Cancer Institute, NIH, 9609 Medical Center Coast Guard District (dpi), by phone at
3292, niw@csr.nih.gov. Drive, Room 7W266, Bethesda, MD 20892, (907) 463–2809, email
Name of Committee: Center for Scientific 240–276–6385, lovingeg@mail.nih.gov. Katharine.E.Martorelli@uscg.mil or by
Review Special Emphasis Panel; Infection, This notice is being published less than 15 mail at P.O. Box 25517, Juneau, Alaska
Complement Activation and Inflammatory days prior to the meeting due to the timing 99802.
Immune Tolerance. limitations imposed by the review and
Date: October 30, 2015. SUPPLEMENTARY INFORMATION:
funding cycle.
Time: 12:00 p.m. to 5:00 p.m. Background and Purpose
Agenda: To review and evaluate grant Name of Committee: National Cancer
applications. Institute Special Emphasis Panel; Omnibus As part of the Oil Pollution Act of
Place: National Institutes of Health, 6701 R03 & R21/SEP–5. 1990, Congress passed the Oil Terminal
Rockledge Drive, Bethesda, MD 20892, Date: November 19–20, 2015. and Oil Tanker Environmental
(Virtual Meeting). Time: 8:00 a.m. to 5:00 p.m. Oversight and Monitoring Act of 1990
Contact Person: Bahiru Gametchu, DVM, Agenda: To review and evaluate grant (the Act), 33 U.S.C. 2732, to foster a
Ph.D., Scientific Review Officer, Center for applications.
Scientific Review, National Institutes of Place: Gaithersburg Marriott
long-term partnership among industry,
Health, 6701 Rockledge Drive, Room 4204, Washingtonian Center, 9751 Washingtonian government, and local communities in
MSC 7812, Bethesda, MD 20892, 301–435– Boulevard, Salon G, Gaithersburg, MD 20878. overseeing compliance with
1225, gametchb@csr.nih.gov. Contact Person: Thomas A. Winters, Ph.D., environmental concerns in the
(Catalogue of Federal Domestic Assistance Scientific Review Officer, Special Review operation of crude oil terminals and oil
Program Nos. 93.306, Comparative Medicine; Branch, Division of Extramural Activities, tankers.
93.333, Clinical Research, 93.306, 93.333, National Cancer Institute, NIH, 9609 Medical On October 18, 1991, the President
93.337, 93.393–93.396, 93.837–93.844, Center Drive, Room 7W412, Bethesda, MD delegated his authority under 33 U.S.C
93.846–93.878, 93.892, 93.893, National 20892–9750, 240–276–6386, twinters@ 2732 (o) to the Secretary of
Institutes of Health, HHS) mail.nih.gov.
Transportation in Executive Order
Dated: September 21, 2015. (Catalogue of Federal Domestic Assistance 12777, section 8(g) (see 56 FR 54757;
Melanie J. Gray, Program Nos. 93.392, Cancer Construction; October 22, 1991) for purposes of
Program Analyst, Office of Federal Advisory 93.393, Cancer Cause and Prevention certifying advisory councils, or groups,
Committee Policy. Research; 93.394, Cancer Detection and
subject to the Act. On March 3, 1992,
Diagnosis Research; 93.395, Cancer
[FR Doc. 2015–24320 Filed 9–24–15; 8:45 am]
Treatment Research; 93.396, Cancer Biology the Secretary re-delegated that authority
BILLING CODE 4140–01–P Research; 93.397, Cancer Centers Support; to the Commandant of the USCG (see 57
93.398, Cancer Research Manpower; 93.399, FR 8582; March 11, 1992). The
Cancer Control, National Institutes of Health, Commandant re-delegated that authority
DEPARTMENT OF HEALTH AND HHS) to the Chief, Office of Marine Safety,
HUMAN SERVICES Security and Environmental Protection
Dated: September 21, 2015.
Melanie J. Gray, (G–M) on March 19, 1992 (letter #5402).
National Institutes of Health On July 7, 1993, the USCG published
Program Analyst, Office of Federal Advisory
National Cancer Institute; Notice of Committee Policy. a policy statement, 58 FR 36504, to
Closed Meetings clarify the factors that shall be
[FR Doc. 2015–24321 Filed 9–24–15; 8:45 am]
considered in making the determination
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the as to whether advisory councils, or
Federal Advisory Committee Act, as groups, should be certified in
amended (5 U.S.C. App.), notice is accordance with the Act.
hereby given of the following meetings. DEPARTMENT OF HOMELAND The Assistant Commandant for
The meetings will be closed to the SECURITY Marine Safety and Environmental
public in accordance with the Protection (G–M), re-delegated
provisions set forth in sections Coast Guard
recertification authority for advisory
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., [USCG–2015–0751] councils, or groups, to the Commander,
as amended. The grant applications and Seventeenth Coast Guard District on
the discussions could disclose Cook Inlet Regional Citizen’s Advisory February 26, 1999 (letter #16450).
confidential trade secrets or commercial Council (CIRCAC) Charter Renewal On September 16, 2002, the USCG
property such as patentable material, published a policy statement, 67 FR
AGENCY: Coast Guard, DHS.
and personal information concerning 58440, that changed the recertification
individuals associated with the grant ACTION: Notice of recertification.
procedures such that applicants are
applications, the disclosure of which SUMMARY: The purpose of this notice is required to provide the USCG with
would constitute a clearly unwarranted to inform the public that the Coast comprehensive information every three
invasion of personal privacy. Guard has recertified the Cook Inlet years (triennially). For each of the two
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: National Cancer Regional Citizen’s Advisory Council years between the triennial application
Institute Special Emphasis Panel; Processes (CIRCAC) as an alternative voluntary procedures, applicants submit a letter
in Cancer Control. advisory group for Cook Inlet, Alaska. requesting recertification that includes a
Date: October 14, 2015. This certification allows the CIRCAC to description of any substantive changes
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant monitor the activities of terminal to the information provided at the
applications. facilities and crude oil tankers under the previous triennial recertification.
Place: National Cancer Institute Shady Cook Inlet Program established by Further, public comment is not solicited
Grove, 9609 Medical Center Drive, Room statute. prior to recertification during
VerDate Sep<11>2014 19:58 Sep 24, 2015 Jkt 235001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\25SEN1.SGM 25SEN1](https://thefederalregister.org/doc/80_FR_58019/page/2.svg)
Document Created: 2018-02-26 10:20:02
Document Modified: 2018-02-26 10:20:02
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | October 14, 2015. | |
| FR Citation | 80 FR 57833 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR